Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 3
1985 3
1986 1
1989 3
1990 3
1991 5
1992 4
1993 2
1994 5
1995 2
1997 3
1998 4
1999 1
2000 4
2001 9
2002 11
2003 6
2004 3
2005 10
2007 7
2008 4
2009 8
2010 5
2011 8
2012 10
2013 13
2014 16
2015 16
2016 7
2017 12
2018 12
2019 10
2020 15
2021 10
2022 20
2023 23
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

253 results

Results by year

Filters applied: . Clear all
Page 1
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
Brown P, Inaba H, Annesley C, Beck J, Colace S, Dallas M, DeSantes K, Kelly K, Kitko C, Lacayo N, Larrier N, Maese L, Mahadeo K, Nanda R, Nardi V, Rodriguez V, Rossoff J, Schuettpelz L, Silverman L, Sun J, Sun W, Teachey D, Wong V, Yanik G, Johnson-Chilla A, Ogba N. Brown P, et al. J Natl Compr Canc Netw. 2020 Jan;18(1):81-112. doi: 10.6004/jnccn.2020.0001. J Natl Compr Canc Netw. 2020. PMID: 31910389
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. Advancements in technology that enhance our understanding of the biology of the disease, risk-adapted therapy, and enhanced supportive care have contributed to improved surviva …
Acute lymphoblastic leukemia (ALL) is the most common pediatric malignancy. Advancements in technology that enhance our unders …
Testicular involvement of acute lymphoblastic leukemia in children and adolescents: Diagnosis, biology, and management.
Nguyen HTK, Terao MA, Green DM, Pui CH, Inaba H. Nguyen HTK, et al. Cancer. 2021 Sep 1;127(17):3067-3081. doi: 10.1002/cncr.33609. Epub 2021 May 25. Cancer. 2021. PMID: 34031876 Free PMC article. Review.
Acute lymphoblastic leukemia (ALL) in children and adolescents can involve the testes at diagnosis or upon relapse. ...For refractory or early-relapse testicular leukemia, newer treatment approaches such as chimeric antigen receptor-modified T (CAR- …
Acute lymphoblastic leukemia (ALL) in children and adolescents can involve the testes at diagnosis or upon relapse. ...For ref …
Remission, treatment failure, and relapse in pediatric ALL: an international consensus of the Ponte-di-Legno Consortium.
Buchmann S, Schrappe M, Baruchel A, Biondi A, Borowitz M, Campbell M, Cario G, Cazzaniga G, Escherich G, Harrison CJ, Heyman M, Hunger SP, Kiss C, Liu HC, Locatelli F, Loh ML, Manabe A, Mann G, Pieters R, Pui CH, Rives S, Schmiegelow K, Silverman LB, Stary J, Vora A, Brown P. Buchmann S, et al. Blood. 2022 Mar 24;139(12):1785-1793. doi: 10.1182/blood.2021012328. Blood. 2022. PMID: 34192312 Free PMC article.
Comparison of treatment strategies in de novo pediatric acute lymphoblastic leukemia (ALL) requires standardized measures of efficacy. ...TF should be defined as failure to achieve CR by a prespecified time point in therapy. Relapse can only be defined in pat …
Comparison of treatment strategies in de novo pediatric acute lymphoblastic leukemia (ALL) requires standardized measures of e …
Mogamulizumab for the treatment of T-cell lymphoma.
Makita S, Tobinai K. Makita S, et al. Expert Opin Biol Ther. 2017 Sep;17(9):1145-1153. doi: 10.1080/14712598.2017.1347634. Epub 2017 Jul 3. Expert Opin Biol Ther. 2017. PMID: 28649848 Review.
T-cell lymphoma is a relatively rare hematologic malignancy that accounts for 10-20% of non-Hodgkin lymphomas. ...Among various subtypes of T-cell lymphomas, adult T-cell leukemia-lymphoma (ATL) has the …
T-cell lymphoma is a relatively rare hematologic malignancy that accounts for 10-20% of non-Hodgkin lymphomas. . …
Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia.
Ryan SL, Peden JF, Kingsbury Z, Schwab CJ, James T, Polonen P, Mijuskovic M, Becq J, Yim R, Cranston RE, Hedges DJ, Roberts KG, Mullighan CG, Vora A, Russell LJ, Bain R, Moorman AV, Bentley DR, Harrison CJ, Ross MT. Ryan SL, et al. Leukemia. 2023 Mar;37(3):518-528. doi: 10.1038/s41375-022-01806-8. Epub 2023 Jan 19. Leukemia. 2023. PMID: 36658389 Free PMC article.
Childhood B-cell acute lymphoblastic leukaemia (B-ALL) is characterised by recurrent genetic abnormalities that drive risk-directed treatment strategies. ...Novel genetic variants, including fusions involving genes in the MAP kinase pathway, were ident …
Childhood B-cell acute lymphoblastic leukaemia (B-ALL) is characterised by recurrent genetic abnormalities that …
Novel precision medicine approaches and treatment strategies in hematological malignancies.
Rosenquist R, Bernard E, Erkers T, Scott DW, Itzykson R, Rousselot P, Soulier J, Hutchings M, Östling P, Cavelier L, Fioretos T, Smedby KE. Rosenquist R, et al. J Intern Med. 2023 Oct;294(4):413-436. doi: 10.1111/joim.13697. Epub 2023 Aug 7. J Intern Med. 2023. PMID: 37424223 Review.
In recent classifications of hematological malignancies, disease subtypes are defined by key recurrent genetic alterations detected by conventional methods (i.e., cytogenetics, fluorescence in situ hybridization, and targeted sequencing). ...In this review, we give example …
In recent classifications of hematological malignancies, disease subtypes are defined by key recurrent genetic alterations detected b …
Targeted Treatment and Immunotherapy in High-risk and Relapsed/ Refractory Pediatric Acute Lymphoblastic Leukemia.
Graiqevci-Uka V, Behluli E, Spahiu L, Liehr T, Temaj G. Graiqevci-Uka V, et al. Curr Pediatr Rev. 2023;19(2):150-156. doi: 10.2174/1573396318666220901165247. Curr Pediatr Rev. 2023. PMID: 36056858 Free PMC article. Review.
Acute lymphoblastic leukemia is the most frequent pediatric malignancy in children, comprising 30% of all pediatric malignancies; adult ALL comprises 5% of all ALL cases, which have a 186.6 per 1 million incidence. ...This review aims to summarize treatment strategi …
Acute lymphoblastic leukemia is the most frequent pediatric malignancy in children, comprising 30% of all pediatric malignanci …
Management of CNS Disease in Pediatric Acute Lymphoblastic Leukemia.
McNeer JL, Schmiegelow K. McNeer JL, et al. Curr Hematol Malig Rep. 2022 Feb;17(1):1-14. doi: 10.1007/s11899-021-00640-6. Epub 2022 Jan 13. Curr Hematol Malig Rep. 2022. PMID: 35025035 Review.
PURPOSE OF REVIEW: The treatment of acute lymphoblastic leukemia (ALL) is one of the success stories of pediatric oncology, but challenges and questions remain, including the optimal approach to the treatment of central nervous system (CNS) leukemia. ...These …
PURPOSE OF REVIEW: The treatment of acute lymphoblastic leukemia (ALL) is one of the success stories of pediatric oncology, bu …
Integrated clinical genotype-phenotype characteristics of early T-cell precursor acute lymphoblastic leukemia.
Ye MT, Wang Y, Zuo Z, Calin S, He H, Tang Z, Jabbour EJ, Borthakur G, Zhang Y, Yang Y, You MJ. Ye MT, et al. Cancer. 2023 Jan 1;129(1):49-59. doi: 10.1002/cncr.34515. Epub 2022 Oct 25. Cancer. 2023. PMID: 36281717 Free article.
BACKGROUND: Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a distinct subtype of T-ALL with a unique immunophenotype and high treatment failure rate. ...TP53 mutation was the only molecular prognostic marker and was asso …
BACKGROUND: Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a distinct subtype of T …
Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment.
Bassan R, Maino E, Cortelazzo S. Bassan R, et al. Eur J Haematol. 2016 May;96(5):447-60. doi: 10.1111/ejh.12722. Epub 2016 Jan 24. Eur J Haematol. 2016. PMID: 26679753 Review.
Lymphoblastic lymphoma is a rare aggressive neoplasm of T-/B-precursors resembling acute lymphoblastic leukemia, with no or limited bone marrow involvement (<25%), that develops more frequently in children and young adults and is typically ch …
Lymphoblastic lymphoma is a rare aggressive neoplasm of T-/B-precursors resembling acute lymphoblastic leukem …
253 results